MedCity News

JANUARY 8, 2024

Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider.

Physicians 115

Physicians Patients 115

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 114

Marketing Pharma Pharmaceutical Patients 114

PM360

DECEMBER 20, 2024

With the use of AI tools, healthcare practitioners (HCPs), researchers, and other industry heavy-hitters can personalize communications with patients, stay more involved with their patients medical journeys, and get to the root of care-without swaying their attention with tediously time-consuming tasksimproving patient health outcomes overall.

Marketing 69

Marketing Healthcare Healthcare Media 69

MedCity News

DECEMBER 26, 2023

In looking ahead to 2024, the healthcare industry stands at the cusp of a transformative era of transparency. With impending regulatory changes and growing consumer empowerment, the landscape is poised for continued meaningful progress.

Healthcare 111

Healthcare Healthcare Patients 111

Referral MD

NOVEMBER 1, 2024

1, 2024 /PRNewswire-PRWeb/ — ReferralMD, a leader in healthcare technology solutions, announced today that it was recognized as a 2024 Top Company in Conversational AI upon the conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace. PLEASANT, S.C. , Nov.

Healthcare 105

Healthcare Healthcare Management CRM 105

European Pharmaceutical Review

APRIL 30, 2024

A positive opinion of a marketing authorisation was granted for Altuvoct (efanesoctocog alfa), as a treatment and prophylaxis of bleeding in patients with the rare blood disorder haemophilia A. CHMP meeting highlights: March 2024 The post CHMP meeting highlights: April 2024 appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Consulting Patients FDA 98

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. Clinical data showed approximately 60 percent reductions in plasma NfL concentrations in patients given Qalsody compared to placebo.

Medicine 98

Medicine Patients Marketing Pharmaceutical 98

European Pharmaceutical Review

MAY 25, 2023

CPHI’s Pharmapack Awards 2024 are open for submissions. The Pharmapack Awards 2024 (January 24-25 2024) will be held during the event’s opening day. The three award categories for the Health Product Awards 2024 are: Patient-Centric Design Award Eco-Design Award Animal Health.

Pharma 95

Pharma Distribution Pharmaceutical Patients 95

European Pharmaceutical Review

JANUARY 30, 2024

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. CHMP’s September 2023 meeting highlights The post CHMP meeting highlights: January 2024 appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Marketing Safety Pharmaceutical 98

MedCity News

FEBRUARY 4, 2024

2024 stands at a critical juncture in the battle against soaring pharmacy costs. If these dual forces converge, they have the power to bring about a transformative shift that can lower drug spend for millions of American patients. In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year.

Prescription 119

Prescription Networking Management Pharmaceutical 119

Pharmaceutical Technology

OCTOBER 21, 2024

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis pigmentosa (RP).

Patients 98

Patients 98

Impetus Digital

JUNE 17, 2024

Simulation-Based Learning Simulation-based learning can allow students to practice clinical skills and make decisions in life-like scenarios without the risk of harming actual patients. It can also simulate patient interactions and provide instant feedback to help HCPs improve their efficiency and accuracy when diagnosing and prescribing.

Education 108

Education Medical Training Media 108

European Pharmaceutical Review

AUGUST 15, 2023

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Pharma Pharmaceutical Pharmaceutical research 98

Eversana Intouch

NOVEMBER 20, 2023

As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors. Pharma/Biotech companies will continue to tailor their market access strategies locally to maximize patient outcomes and drive commercial value.

Marketing 105

Marketing Healthcare Healthcare Pharma 105

European Pharmaceutical Review

JULY 5, 2024

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharma 98

Pharma Government Safety Medicine 98

PharmaVoice

OCTOBER 22, 2024

Leaders advancing health advocacy, DEI initiatives and better medicine access for patients.

Patients 75

Patients Medicine 75

pharmaphorum

AUGUST 31, 2022

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The post Novartis extends Kaiku digital patient monitoring partnership appeared first on.

Patients 116

Patients Electronics Management Pharma 116

World of DTC Marketing

AUGUST 30, 2022

Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024. Display is an incredibly low-effort way to spend your marketing budget, whether trying to reach physicians or patients. For patients, using banner ads is the most significant waste of money in DTC budgets.

Physicians 270

Physicians Marketing Pharma Insurance 270

European Pharmaceutical Review

MAY 29, 2024

Furthermore, Biomica highlighted that one patient demonstrated partial response and is “actively responding to treatment”. The combination therapy halted disease progression in 64 percent of patients. Sustained clinical benefit was observed in 55 percent of patients.

Patients 98

Patients Safety Medicine Medical 98

PM360

DECEMBER 20, 2024

DxCheck Launched in 2023, DxCheck is an AI-powered digital health platform that has swiftly emerged as a leader in personalized patient engagement across rare diseases, chronic conditions, and oncology. update in 2024 introduced enhanced diagnostic tools and personalized health assessments, further elevating its capabilities.

Healthcare 52

Healthcare Healthcare Patients Medical 52

Pharmaceutical Commerce

MARCH 21, 2024

A multiple myeloma survivor shares his story, including how patient assistance made a positive impact.

Patients 104

Patients 104

PM360

FEBRUARY 12, 2024

Created by The European Organization for Rare Diseases (EURORDIS) , this globally coordinated event brings together industry stakeholders to advocate for increased access to medical treatment for patients, caregivers, and their families.

Food and Drug Administration 105

Food and Drug Administration Patients Medical Networking 105

Impetus Digital

FEBRUARY 16, 2024

In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option. In this article, we’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put this idea to rest.

Pharma 84

Pharma Healthcare Provider Healthcare Healthcare 84

PM360

DECEMBER 20, 2024

Courier Health Powered by machine learning AI, Avalere Courier Health was founded in 2021 with the goal of revolutionizing the biopharma landscape with its groundbreaking patient-focused customer relationship management (CRM) platform. In July 2024, Courier Health secured $16.5 It simplifies complex workflows (e.g.,

Customer Relationship Management 52

Customer Relationship Management CRM Biopharma Relationship management 52

Pharmaceutical Technology

MAY 13, 2024

As the debate over using tau levels to guide patient treatment persists, the landscape for Alzheimer’s diagnostics continues to move ahead.

Patients 98

Patients 98

World of DTC Marketing

DECEMBER 4, 2020

SUMMARY: McKinsey estimates that global digital-health revenues—from telemedicine, online pharmacies, wearable devices, and so on—will rise from $350bn last year to $600bn in 2024. Some 70% of American hospitals still fax and post patient records, and patients don’t have one record to share among all their doctors.

Medicine 201

Medicine Doctors Medical Media 201

PharmaTimes

NOVEMBER 27, 2023

The IRP will bring life-saving medicines to UK patients from 1 January 2024 - News - PharmaTimes

Medicine 113

Medicine Patients 113

PM360

DECEMBER 20, 2024

Swoop Launched in September 2024, the Swoop HCP Pro Suite is revolutionizing how pharmaceutical marketers engage with healthcare providers (HCPs). This innovation equips marketers with the tools to deliver personalized, omnichannel communications and foster meaningful interactions that enhance patient care.

Prescription 52

Prescription Healthcare Provider Insurance Marketing 52

Pharmaceutical Technology

OCTOBER 13, 2023

The Phase IIb SurVaxM vaccine study will enrol 265 patients and has an estimated completion date in Q2 2024.

FDA 111

FDA Patients 111

Pharmaceutical Technology

DECEMBER 11, 2024

The prevailing treatment paradigm for newly diagnosed multiple myeloma (NDMM) patients who have received autologous stem cell transplantation (SCT) primarily consists of chemotherapy or Johnson & Johnsons (J&J) Darzalex in combination with chemotherapy.

Patients 59

Patients 59

PM360

DECEMBER 20, 2024

Bloqcube To accelerate clinical trials, enhance data integrity, recruit diverse patients, and reduce the risk of ransomware attacks, Bloqcube developed BloqWeb for small to midsize Sites, and CROs. As an innovative eClincial software company, Bloqcube aims to improve the efficiency of clinical trials. Essentiallycheaper, faster, better.

Competition 52

Competition Recruitment FDA Healthcare 52

PM360

OCTOBER 31, 2024

[Cedar Knolls, 10/29/2024] — A recent study conducted by PURE , the industry’s premier benchmark for evaluating patient support programs (PSPs), has named the best-in-class PSPs across key therapeutic areas. Kulstad commented: “These results provide an insightful roadmap for the future of patient support programs.

Patients 52

Patients Education Consulting Healthcare 52

Pharmaceutical Commerce

DECEMBER 16, 2024

Kevin OMeara discusses how patient service teams influence adherence from Direct-to-Patient models.

Patients 52

Patients 52

PM360

DECEMBER 20, 2024

After nearly five years of mounting pressures on the American healthcare system, providers and patients are confronting another challenge that shows no signs of slowing down: skyrocketing medical costs. Patients with low incomes are especially vulnerable.

Patients 52

Patients Prescription Retail Insurance 52

European Pharmaceutical Review

OCTOBER 3, 2024

The post <em>European Pharmaceutical Review </em> Issue 4 2024 appeared first on European Pharmaceutical Review. Preparing for the impact of EU GMP Annex 1 on primary packaging Niamh Bissett and Dr Ana Kuschel West Pharmaceutical Services, Inc. Login or create an account to download your copy of our Issue now!

Pharmaceutical 59

Pharmaceutical Consulting Manufacturing FDA 59

Pharmaceutical Commerce

DECEMBER 12, 2024

Kevin OMeara discusses Patient-Cetric 3.0 breakout session and the challenges of drug manufactures implementing Direct-to-Patient models.

Patients 52

Patients Manufacturing 52

Pharmaceutical Commerce

DECEMBER 11, 2024

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.

Patients 52

Patients 52